Medivir AB announced that the first patient with hepatocellular carcinoma has started treatment in phase 2a with the candidate drug fostroxacitabine bralpamide in combination with Lenvima®.
European biotech AlgoTx, the developer of first-in-class treatment ATX01 for chemotherapy-induced peripheral neuropathy, announced the success of a €20M Series B fundraising led by Relyens Innovation Santé / Turenne Capital, followed by UI Investissement, and historical investors Bpifrance through its Innobio 2 fund and Omnes Capital.
AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain Read More »
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient developed by Mitsui Chemicals Agro which has a different mode of action from existing vector control products.
La banca electrónica La banca nació en el año 1995, en el momento que los grandes bancos comenzaron a crear sus portales web, esto con la finalidad de crear facilidades al momento de las transacciones, lo que facilitaría las compras por internet, las ap …
Albumedix Ltd, Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc, Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin® is a critical component of Heartseed’s HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing.
Las pruebas de diagnóstico apropiadas con tiempos de respuesta rápidos reducen el uso excesivo de antibióticos
Criterios en el ámbito hospitalario | Optimización de la prescripción de antimicrobianos Read More »
The activist investor said his board nominees would work to prevent Illumina from “sinking further into the quicksand” in a battle with regulators over the Grail acquisition.
Illumina shares jump 17% after Icahn launches proxy fight Read More »
Julia Strandberg, formerly Pear’s chief commercial officer, must revive a division still struggling with the recall of 5.5 million respirators.
Philips poaches new connected care business leader from Pear Read More »
The major healthcare and life sciences lender closed Friday in the culmination of a rapid four-day nosedive that left some healthcare companies temporarily locked out of funds.
Fall of SVB hits healthcare sector as federal regulators step in Read More »
A review of companies covered by analysts reveals no significant direct exposure to SVB’s failure, but startups dependent on venture capital cash may be affected.
